Dr. Jeffrey L. Cummings In The News
Neurology Live
A systematic review of Alzheimer disease (AD) treatments currently in development demonstrate the progressive emphasis on nonamyloid targets, including candidate treatments addressing for inflammation, synapse and neuronal protection, vascular factors, neurogenesis, and epigenetic interventions.
Philanthropy News Digest
The ÐÔÊӽ紫ý has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.